A detailed history of Citizens National Bank Trust Department transactions in Organon & Co. stock. As of the latest transaction made, Citizens National Bank Trust Department holds 2,370 shares of OGN stock, worth $34,910. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,370
Previous 2,370 -0.0%
Holding current value
$34,910
Previous $49,000 8.16%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$13.78 - $18.8 $41 - $56
-3 Reduced 0.13%
2,370 $44,000
Q2 2023

Jul 24, 2023

SELL
$19.27 - $24.63 $3,468 - $4,433
-180 Reduced 7.05%
2,373 $49,000
Q2 2022

Jul 28, 2022

BUY
$31.66 - $38.9 $80,827 - $99,311
2,553 New
2,553 $86,000
Q1 2022

May 10, 2022

SELL
$30.45 - $39.36 $13,885 - $17,948
-456 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$28.67 - $37.13 $13,073 - $16,931
456 New
456 $14,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Citizens National Bank Trust Department Portfolio

Follow Citizens National Bank Trust Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens National Bank Trust Department, based on Form 13F filings with the SEC.

News

Stay updated on Citizens National Bank Trust Department with notifications on news.